Some DUBs, such as USP7, USP36, and USP13, function to stabilize key oncogenic proteins by preventing their proteasomal degradation, thereby facilitating tumor growth [10–12] Consequently, DUB inhibitors may serve as effective therapeutic agents for cancer [13, 14]. This evidence concerns the gene ZUP1 and cancer.